As of Oct. 19, Cigna will deny claims billed with codes for consultation services, making it the second payer to discontinue payment for evaluation and management codes in 2019.
Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes
Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.
RheumPAC Advocates for Dept. of Defense Arthritis Research Funding
RheumPAC is the ACR’s non-partisan political action committee, which promotes the needs of rheumatology providers and patients. Advocacy efforts often focus on legislation to improve the day-to-day clinical care of rheumatology patients, such as establishing clinical exceptions to step therapy requirements and reforming the prior authorization process. In addition, the ACR and RheumPAC recognize the…
Patients & Physicians Unite for Arthritis Advocacy
Nearly 120 ACR/ARP member advocates and rheumatology patients were on Capitol Hill this week fighting for rheumatology as part of the ACR’s Advocates for Arthritis conference.
Advocates for Arthritis Will Target Step Therapy, Workforce Shortage
The 2019 event, to be held Sept. 9-10 in Washington, D.C., will bring together rheumatology professionals and patients to advocate on behalf of the rheumatology community.
CMS Proposes Major Payment Increases for E/M Services
CMS estimates that under their proposal, released July 29, rheumatologists would see on average a 15% payment increase, beginning in 2021.
RheumPAC Advocates for Department of Defense Arthritis Research Funding
The ACR’s nonpartisan political action committee is continuing to advocate for increased defense department funding for rheumatology research. Learn about RheumPAC’s efforts and how you can help.
White House Preparing Order that Would Cut Drug Prices for Medicare
(Reuters)—U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government programs, according to two industry sources who had discussions with the White House. The order under discussion would be much broader than the Administration’s previously disclosed proposal to lower…
Drug Makers Met with Trump to Argue against Senate Pricing Bill
(Reuters)—The main pharmaceutical industry lobbying group said on Thursday it and some drugmakers met with President Donald Trump to voice opposition to a bipartisan U.S. Senate bill that aims to lower prescription drug prices. The White House, which has said it backs the legislation, has promised to bring down drug prices for U.S. consumers, an…
Top 2020 Contenders Snipe over Healthcare Policy
WASHINGTON (Reuters) – Democratic presidential front-runner Joe Biden and rival Bernie Sanders are waging a public battle this week over universal healthcare, staking out competing turf on an issue that has become the most divisive in the party’s primary campaign. The sniping between the two White House contenders, highlighted on Wednesday when Sanders delivered a…
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 86
- Next Page »